Works by Brown, Lisha
Results: 21
Targeting the fibroblast growth factor pathway in molecular subtypes of castration‐resistant prostate cancer.
- Published in:
- Prostate, 2024, v. 84, n. 1, p. 100, doi. 10.1002/pros.24630
- By:
- Publication type:
- Article
Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26042-z
- By:
- Publication type:
- Article
Cellular Adhesion Promotes Prostate Cancer Cells Escape from Dormancy.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0130565
- By:
- Publication type:
- Article
Cabozantinib can block growth of neuroendocrine prostate cancer patient-derived xenografts by disrupting tumor vasculature.
- Published in:
- PLoS ONE, 2021, v. 16, n. 1, p. 1, doi. 10.1371/journal.pone.0245602
- By:
- Publication type:
- Article
LNCaP produces both putative zymogen and inactive, free form of prostate-specific antigen.
- Published in:
- Prostate, 1998, v. 35, n. 2, p. 135, doi. 10.1002/(SICI)1097-0045(19980501)35:2<135::AID-PROS7>3.0.CO;2-I
- By:
- Publication type:
- Article
Inhibition of CCL2 Signaling in Combination with Docetaxel Treatment Has Profound Inhibitory Effects on Prostate Cancer Growth in Bone.
- Published in:
- International Journal of Molecular Sciences, 2013, v. 14, n. 5, p. 10483, doi. 10.3390/ijms140510483
- By:
- Publication type:
- Article
Host-derived RANKL is responsible for osteolysis in a C4-2 human prostate cancer xenograft model of experimental bone metastases.
- Published in:
- BMC Cancer, 2007, v. 7, p. 148, doi. 10.1186/1471-2407-7-148
- By:
- Publication type:
- Article
Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment.
- Published in:
- BMC Cancer, 2006, v. 6, p. 15, doi. 10.1186/1471-2407-6-15
- By:
- Publication type:
- Article
Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease and Serve as Models for Evaluating Cancer Therapeutics.
- Published in:
- Prostate, 2017, v. 77, n. 6, p. 654, doi. 10.1002/pros.23313
- By:
- Publication type:
- Article
Addition of PSMA ADC to enzalutamide therapy significantly improves survival in in vivo model of castration resistant prostate cancer.
- Published in:
- Prostate, 2016, v. 76, n. 3, p. 325, doi. 10.1002/pros.23124
- By:
- Publication type:
- Article
Efficacy studies of an antibody-drug conjugate PSMA-ADC in patient-derived prostate cancer xenografts.
- Published in:
- Prostate, 2015, v. 75, n. 3, p. 303, doi. 10.1002/pros.22916
- By:
- Publication type:
- Article
The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells.
- Published in:
- Prostate, 2010, v. 70, n. 4, p. 412, doi. 10.1002/pros.21075
- By:
- Publication type:
- Article
Nemo-like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cells.
- Published in:
- Prostate, 2009, v. 69, n. 14, p. 1481, doi. 10.1002/pros.20998
- By:
- Publication type:
- Article
Prostate cancer expression of runt-domain transcription factor Runx2, a key regulator of osteoblast differentiation and function.
- Published in:
- Prostate, 2003, v. 56, n. 1, p. 13, doi. 10.1002/pros.10233
- By:
- Publication type:
- Article
Establishment and characterization of osseous prostate cancer models: Intra-tibial injection of human prostate cancer cells.
- Published in:
- Prostate, 2002, v. 52, n. 1, p. 20, doi. 10.1002/pros.10091
- By:
- Publication type:
- Article
Epithelial mesenchymal-like transition occurs in a subset of cells in castration resistant prostate cancer bone metastases.
- Published in:
- Clinical & Experimental Metastasis, 2016, v. 33, n. 3, p. 239, doi. 10.1007/s10585-015-9773-7
- By:
- Publication type:
- Article
Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment.
- Published in:
- Clinical & Experimental Metastasis, 2014, v. 31, n. 2, p. 247, doi. 10.1007/s10585-013-9625-2
- By:
- Publication type:
- Article
Methylation profiling identified novel differentially methylated markers including OPCML and FLRT2 in prostate cancer.
- Published in:
- Epigenetics, 2016, v. 11, n. 4, p. 247, doi. 10.1080/15592294.2016.1148867
- By:
- Publication type:
- Article
A bladder cancer patient-derived xenograft displays aggressive growth dynamics in vivo and in organoid culture.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-83662-7
- By:
- Publication type:
- Article
Cabozantinib Inhibits Growth of Androgen-Sensitive and Castration-Resistant Prostate Cancer and Affects Bone Remodeling.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0078881
- By:
- Publication type:
- Article